ORSI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 633
NA - Nord America 576
EU - Europa 368
SA - Sud America 144
AF - Africa 12
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.742
Nazione #
US - Stati Uniti d'America 547
SG - Singapore 231
CN - Cina 201
IT - Italia 137
BR - Brasile 123
HK - Hong Kong 100
DE - Germania 49
SE - Svezia 43
VN - Vietnam 34
GB - Regno Unito 27
IN - India 21
CA - Canada 19
NL - Olanda 17
RU - Federazione Russa 17
FI - Finlandia 16
PL - Polonia 15
AR - Argentina 13
ES - Italia 11
JP - Giappone 11
FR - Francia 10
MX - Messico 9
ZA - Sudafrica 9
AU - Australia 8
AT - Austria 7
BD - Bangladesh 5
KR - Corea 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IE - Irlanda 4
PK - Pakistan 4
TR - Turchia 4
BE - Belgio 3
ID - Indonesia 3
IQ - Iraq 3
LT - Lituania 3
AL - Albania 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
IR - Iran 2
PY - Paraguay 2
VE - Venezuela 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 1.742
Città #
Singapore 138
Dallas 131
Hong Kong 97
Ashburn 78
Beijing 48
Shanghai 42
Boardman 36
Milan 36
Hefei 31
New York 29
Los Angeles 26
Warsaw 15
Cesano Boscone 14
Nuremberg 11
Hanoi 10
Stockholm 10
Chicago 9
Helsinki 9
Munich 9
Santa Clara 9
São Paulo 9
Tokyo 9
Amsterdam 8
Boston 8
Brooklyn 8
Phoenix 8
Rome 8
Falkenstein 7
Frankfurt am Main 7
Ho Chi Minh City 7
Lawrence 7
Montreal 7
Princeton 7
Rio de Janeiro 7
Seattle 7
Brescia 6
Denver 6
London 6
Moscow 6
Mumbai 6
Sydney 6
Brasília 5
Carlsbad 5
Johannesburg 5
Mexico City 5
Naples 5
Orem 5
Vienna 5
Bologna 4
Campinas 4
Chennai 4
Houston 4
Hyderabad 4
Lappeenranta 4
Pisa 4
The Dalles 4
Turin 4
Atlanta 3
Bellpuig 3
Brussels 3
Buffalo 3
Dublin 3
Essen 3
Guangzhou 3
Manchester 3
Mezzolombardo 3
Milton Keynes 3
Montes Claros 3
Ottawa 3
Poplar 3
Porto Alegre 3
Querétaro 3
Romagnano Sesia 3
San Francisco 3
Seocho-gu 3
Toronto 3
Turku 3
Ankara 2
Annapolis 2
Bagé 2
Baie-D'Urfé 2
Belo Horizonte 2
Berlin 2
Bexley 2
Bolzano 2
Boulogne Sur Mer 2
Brisbane 2
Calgary 2
Cape Town 2
City of London 2
Cuiabá 2
Cuneo 2
Curitiba 2
Daejeon 2
Dhaka 2
Fuzhou 2
Guiyang 2
Haiphong 2
Hundested 2
João Pessoa 2
Totale 1.115
Nome #
ANALYSIS OF THE ACTIVITY OF NOVEL RADIOSENSITIZERS AND SYSTEMIC TREATMENTS IN PANCREATIC ADENOCARCINOMA: A ROAD MAP TO IMPROVE THE OUTCOME IN LOCALLY ADVANCED DISEASE. 102
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 91
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 81
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 71
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants 66
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 63
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 62
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 60
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 59
The impact of nutritional status on pancreatic cancer therapy 59
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 58
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease 56
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 56
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 55
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 55
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life 52
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 52
Lessons and open questions in borderline resectable pancreatic cancer 50
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 50
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 49
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 49
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 47
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 47
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey. 46
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 44
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 42
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 41
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 39
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) 38
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 38
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 33
Pancreatic cancer: still a cold case? 32
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma 25
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology 24
The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis 24
null 5
Totale 1.821
Categoria #
all - tutte 9.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.895


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202368 14 11 5 0 1 16 3 10 2 0 6 0
2023/2024157 12 9 12 31 15 18 5 15 4 10 5 21
2024/2025591 39 11 19 22 29 59 89 78 57 68 56 64
2025/2026996 201 168 135 259 222 11 0 0 0 0 0 0
Totale 1.821